High Fidelity of Yellow Fever Virus RNA Polymerase

Journal of Virology

Volumn 78, Issue 2, 2004, Pages 1032-1038

  Pugachev, Konstantin V ^a   Guirakhoo, Farshad ^a   Ocran, Simeon W ^a   Mitchell, Fred ^a   Parsons, Megan ^a   Penal, Caroline ^a   Girakhoo, Soheila ^a   Pougatcheva, Svetlana O ^a   Arroyo, Juan ^a,b   Trent, Dennis W ^a   Monath, Thomas P ^a  

^a Acambis   (United States)

^b DynPort Vaccine Company LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; E PROTEIN; NS4B PROTEIN; NUCLEOTIDE; PRM PROTEIN; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; YELLOW FEVER VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; DENGUE VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS ASSEMBLY; VIRUS CULTURE; VIRUS ENVELOPE; VIRUS GENOME; VIRUS MUTATION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSCRIPTION; YELLOW FEVER FLAVIVIRUS;

DENGUE; DENGUE VIRUS; DNA-DIRECTED RNA POLYMERASES; PLAQUE ASSAY; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; TRANSCRIPTION, GENETIC; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRUS ASSEMBLY; VIRUS REPLICATION; YELLOW FEVER VIRUS;

EID: 9144226530     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.2.1032-1038.2004     Document Type: Article

References (38)

1. Allison, S. L., K. Stadler, C. W. Mandl, C. Kunz, and F. H. Heinz. 1995. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69:5816-5820.
2. Brinton, M. A. 1986. Replication of flaviviruses, p. 327. In S. Schlesinger and M. J. Schlesinger (ed.), The Togaviridae and Flaviviridae. Plenum Press, New York, N.Y.
3. Burke, D. S., and T. P. Monath. 2001. Flaviviruses, p. 1043-1126. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, Pa.
4. Chambers, T. J., C. S. Hahn, R. Galler, and C. M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44:649-688.
5. Chambers, T. J., A. Nestorowicz, P. W. Mason, and C. M. Rice. 1999. Yellow fever/Japanese encephalitis chimeric virus: construction and biological properties. J. Virol. 73:3095-3101.
6. Chumakov, K. M., L. B. Powers, K. E. Noonan, I. B. Roninson, and I. S. Levenbook. 1991. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. USA 88:199-203.
7. Domingo, E., C. Escarmis, N. Sevilla, A. Moya, S. F. Elena, J. Quer, I. S. Novella, and J. J. Holland. 1996. Basic concepts in RNA virus evolution. FASEB J. 10:859-864.
8. Drake, J. W., B. Charlesworth, D. Charlesworth, and J. F. Crow. 1998. Rates of spontaneous mutation. Genetics 148:1667-1686.
9. Elena, S. F., R. Mirales, J. M. Cuevas, P. E. Turner, and A. Moya. 2000. The two faces of mutation: extinction and adaptation in RNA viruses. IUBMB Life 49:5-9.
10. Elena, S. F., and A. Moya. 1999. Rate of deleterious mutation and the distribution of its effects on fitness in vesicular stomatitis virus. J. Evol. Biol. 12:1078-1088.
11. Guirakhoo, F., J. Arroyo, K. V. Pugachev, C. Miller, Z.-X. Zhang, R. Weltzin, K. Georgakopoulos, J. Catalan, S. Ocran, K. Soike, M. Ratterree, and T. P. Monath. 2001. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J. Virol. 75:7290-7304.
12. Guirakhoo, F., K. Pugachev, J. Arroyo, C. Miller, Z.-X. Zhang, K. Weltzin, K. Georgakopoulos, J. Catalan, S. Ocran, K. Draper, and T. P. Monath. 2002. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Virology 298:146-159.
13. Hahn, C. S., J. M. Dalrymple, J. H. Strauss, and C. M. Rice. 1987. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc. Natl. Acad. Sci. USA 84:2019-2023.
14. Huang, J., L. G. Brieba, and R. Sousa. 2000. Misincorporation by wild-type and mutant T7 RNA polymerases: identification of interactions that reduce misincorporation rates by stabilizing the catalytically incompetent open conformation. Biochemistry 39:11571-11580.
15. Khromykh, A. A., P. L. Sedlak, and E. G. Westaway. 2000. cis- and trans-acting elements in flavivirus RNA replication. J. Virol. 74:3253-3263.
16. Kofler, R. M., F. X. Heinz, and C. D. Mandl. 2002. Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J. Virol. 76:3534-3543.
17. Konan, K. V., T. H. Giddings, Jr., M. Ikeda, K. Li, S. M. Lemon, and K. Kirkegaard. 2003. Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J. Virol. 77:7843-7855.
18. Kuhn, R. J., W. Zhang, M. G. Rossmann, S. V. Pletnev, J. Corver, E. Lenches, C. T. Jones, S. Mukhopadhyay, P. R. Chipman, E. G. Strauss, T. S. Baker, and J. H. Strauss. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717-725.
19. Kummerer, B. M., and C. M. Rice. 2002. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J. Virol. 76:4773-4784.
20. Lin, C., S. M. Amberg, T. J. Chambers, and C. M. Rice. 1993. Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J. Virol. 67:2327-2335.
21. Lindenbach, B. D., and C. M. Rice. 2001. Flaviviridae: the viruses and their replication, p. 991-1041. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, Pa.
22. Liu, W. J., P. L. Sedlak, N. Kondratieva, and A. A. Khromykh. 2002. Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly. J. Virol. 76:10766-10775.
23. Lorenz, I. C., S. L. Allison, F. X. Heinz, and A. Helenius. 2002. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J. Virol. 76:5480-5491.
24. Lundin, M., M. Monne, A. Widell, G. Von Heijne, and M. A. Persson. 2003. Topology of the membrane-associated hepatitis C virus protein NS4B. J. Virol. 77:5428-5438.
25. Mackenzie, J. M., A. A. Khromykh, M. K. Jones, and E. G. Westaway. 1998. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 245:203-215.
26. Mandl, C. W., H. Kroschewski, S. L. Allison, R. Kofler, H. Holzmann, T. Meixner, and F. H. Heinz. 2001. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J. Virol. 75:5627-5637.
27. Meyerhans, A., and J.-P. Vartanian. 1999. The fidelity of cellular and viral polymerases and its manipulation for hypermutagenesis, p. 87-114. In E. Domingo, R. Webster, and J. Holland (ed.), Origin and evolution of viruses. Academic Press, New York, N.Y.
28. Monath, T. P., K. Soike, I. Levenbook, Z.-X. Zhang, J. Arroyo, S. Delagrave, G. Myers, A. D. T. Barrett, R. E. Shope, M. Ratterree, T. J. Chambers, and F. Guirakhoo. 1999. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 17:1869-1882.
29. Monath, T. P., J. Arroyo, C. Miller, and F. Guirakhoo. 2001. West Nile virus vaccine. Curr. Drug Trends Infect. Disorders. 1:37-50.
30. Monath, T. P., K. McCarthy, P. Bedford, C. T. Johnson, R. Nichols, S. Yoksan, R. Marchesani, M. Knauber, K. H. Wells, J. Arroyo, and F. Guirakhoo. 2002. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 20:1004-1018.
31. Mutebi, J.-P., H. Wang, L. Li, J. E. Bryant, and A. D. T. Barrett. 2001. Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J. Virol. 75:6999-7008.
32. Pugachev, K. V., S. W. Ocran, F. Guirakhoo, D. Furby, and T. P. Monath. 2002. Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing. Vaccine 20:996-999.
33. Ramirez, B.-C., P. Barbier, K. Seron, A.-L. Haenni, and F. Bernardi. 1995. Molecular mechanisms of point mutations in RNA viruses, p. 105-118. In A. Gibbs, C. H. Calisher, and F. García-Arenal (ed.), Molecular basis of virus evolution. Cambridge University Press, Cambridge, England.
34. Rey, F. A., F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375:291-298.
35. Westaway, E. G. 1980. Replication of flaviviruses, p. 531-581. In The togaviruses: biology, structure, replication. Academic Press, New York, N.Y.
36. Westaway, E. G., A. A. Khromykh, M. T. Kenney, J. M. Mackenzie, and M. K. Jones. 1997. Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus. Virology 234:31-41.
37. Westaway, E. G., J. M. Mackenzie, M. T. Kenney, M. K. Jones, and A. A. Khromykh. 1997. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 71:6650-6661.
38. Xie, H., A. R. Cass, and A. D. T. Barrett. 1998. Yellow fever 17D vaccine virus isolated from healthy vaccines accumulates very few mutations. Virus Res. 55:93-99.